Sino-India Pharmaceutical Exchange

Thank you for joining us. The live stream webinar ended with great success.

Recordings and presentation documents are available under each topic. If any problem, feel free to contact Ms. Tinny Yao via Tinny.yao@imsinoexpo.com

INTRODUCTION

China has already entered post-COVID era from late 2020 with full resumption of work and production. While China is working to give full play to its huge domestic market, it is still committed to intercountry cooperation. More and more overseas pharma companies are exploring business and partnership opportunities in China, eager for a share of the big cake.

In the past 3 to 4 years, industry structure in pharmaceuticals has changed with remarkable shifts in the leader board. Four of the top ten players, including the market leader, are new entrants. India and China are mutual reliable partner especially in pharma industry. For Indian API and finished dosage companies, internationalization is a common pursuit, and the growing Chinese pharmaceutical market is an opportunity deserving to be firmly grasped. Therefore, it is important to understand China's constantly updated drug registration and review, approval policies and procedures, and to find local reliable and committed partners to efficiently expand business.

CPHI & PMEC China launches the “E-Trade Season” from March - June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. This includes months of informative content and a targeted matchmaking service - delivering over 8 themed webinar series and showcasing high-quality pharma suppliers from 4 popular themes. The Sino-India Pharmaceutical Exchange Session will focus on Indian and Chinese pharma market, building a learning and networking platform and contributing to the advancement of the connection between India & China.

TOPICS

Development Trend of China’s API Industry and Cooperation Prospect with India

Speaker:
Mr. Renzong ZHU | Deputy Secretary of Sub-chamber from China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)
Content:
● Overview of China’s API industry development and its position in the global market
● China’s current API import & export situation
● Analysis and prospect of cooperation between India and China on API industry

PLAYBACK

DOWNLOAD PRESENTATION
Requirements and Practices of Imported Drug Registration in China

Speaker:
Mr. Steven YU | International Business Director, China Chinopharma Limited
Content:
● API market comparison between India and China
● Strategies to better enter the Chinese market
● Drug registration requirements and procedures in China
● Process and contents of on-site audit

PLAYBACK

DOWNLOAD PRESENTATION
Indian Pharmaceuticals Impacting Global Health and Opportunities to Collaborate with Chinese Pharma

Speaker:
Mr. Sumit Kumar | VP & Region Head API Marketing and Sales, Dr. Reddy's Laboratories
Mr. Yuan CAO | Sales Director, Dr. Reddy’s Laboratories
Content:
● The role of API and generics development and manufacturing in India
● How this creates value for the Chinese market

PLAYBACK

DOWNLOAD PRESENTATION
Panel Discussion: How to build a win-win partnership in pharma industry between China and India

Moderator:
Rosy TU from CCCMHPIE
Guests:
Renzong ZHU from CCCMHPIE, Steven YU from China Chinopharma, Sumit Kumar from Dr. Reddy’s Laboratories

PLAYBACK

【Copyright Notice】

Unless being authorized by the organizers, every institution or individual is not allowed to copy and quote the contents or views in this webcast. If violating the rules above, the organizer and the speakers reserve the right to pursue relevant legal responsibilities of the infringer.

Who Will Attend?

API/ Finished Dosage Manufacturer
R&D Department
CRO Company
Production Department
Consulting Company
Registration Department
Trading/ Import & Export/ Indenting Company
Investment and Acquisition Department

SPONSOR

China Chinopharma Limited

CHINA CHINOPHARMA LTD. (CSC) was established in 2002, and is a pharmaceutical agency. CSC has GSP certificate, and permit license of dealing anesthetic and psychoactive drugs.

CSC handles MA application, patent application, trademark registration, sales & marketing by bearing all costs.

CSC has 72 approved and 63 filed APIs, over 150 molecules awaiting to be filed.

Many molecules that CSC agents occupy over 50% market share for years.

CSC has grand self-owned registration team with over 40 team members and 1,900SQM warehouse.

SPEAKERS

Mr. Renzong ZHU

Deputy Secretary of Sub-chamber from China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)

Renzong ZHU was graduated from Peking University as Master of Science in Chemical Biology and Bachelor of Economics in National Institute of Development. He’s also a licensed pharmacist.

Since joining CCCMHPIE from 2013, Mr. ZHU has devoted himself to chemical APIs research, and has developed in-depth and unique insights on industry policies, markets and enterprises, etc. He’s also invited and engaged in a number of pharmaceutical research projects launched by Ministry of Commerce of China, Ministry of Industry and Information Technology of China, and General Administration of Customs, etc.

He has published nearly a hundred articles on the API industry research in famous Chinese newspapers and magazines. He has been invited for several newspaper interviews and to deliver keynote speeches at many pharmaceutical conferences.
Mr. Steven YU

International Business Director from China Chinopharma Limited

Steven has been working in pharmaceutical industry for over 10 years. Currently he is the Director of International Trade Dept. of CSC (China Chinopharma Ltd.), in charge of the three modules including Business development, regulatory and supply chain management.

He has unique insights and in-depth understanding in pharmaceutical industry dynamics, market prospects, registration key points and drug regulations. More importantly, he has specific understanding of Indian pharmaceutical manufacturers’ expectation & concerns towards China market.
Mr. Sumit Kumar

VP & Region Head API Marketing and Sales from Dr. Reddy's Laboratories

Sumit Kumar is currently working as VP & Region Head for API Marketing and Sales at Dr. Reddy’s Laboratories Ltd. Sumit, an MBA in International Business has also undergone a Post Graduate Diploma course in Intellectual Property. He has more than 20 years of experience in the Pharmaceutical Industry, focusing on Active Pharmaceutical Ingredients (APIs) and working with customers in Asia (including China, Japan, India), and Africa.
Mr. Yuan CAO

Sales Director from Dr. Reddy’s Laboratories

Yuan holds a postgraduate degree in Pharmacy Administration from China Pharmaceutical University. He has over ten years of experience in the Pharmaceutical Industry, focusing on Active Pharmaceutical Ingredients (APIs) for the Chinese market.

PARTNERS

Pharmexcil

Pharmaceuticals Export Promotion Council of India

Pharmexcil was established by the Govt of India to facilitate the exports of Pharmaceuticals and allied products from India. It acts as an interface between the Industry, Government, and International agencies and advocates for its 4000 members on policy matters related to exports. With the support of Pharmexcil, many pharma companies have emerged as big giants in the global marketplace.